Walleye Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.36M Buy
1,177,370
+1,163,486
+8,380% +$6.96M 0.03% 647
2025
Q4
$96.5K Buy
+13,884
New +$91.3K ﹤0.01% 3885
2025
Q2
Sell
-162,173
Closed -$1.05M 4522
2025
Q1
$1.05M Buy
162,173
+139,069
+602% +$999K ﹤0.01% 1932
2024
Q4
$186K Buy
23,104
+19,337
+513% +$159K ﹤0.01% 3812
2024
Q3
$30.7K Buy
3,767
+3,067
+438% +$20.2K ﹤0.01% 4738
2024
Q2
$4.88K Sell
700
-14,695
-95% -$111K ﹤0.01% 5317
2024
Q1
$163K Buy
+15,395
New +$135K ﹤0.01% 4098
2020
Q2
Sell
-16,363
Closed -$254K 621
2020
Q1
$254K Buy
+16,363
New +$395K 0.06% 379
2019
Q4
Sell
-80,218
Closed -$2.09M 1796
2019
Q3
$1.75M Buy
80,218
+58,487
+269% +$1.34M 0.1% 252
2019
Q2
$548K Buy
21,731
+21,031
+3,004% +$499K 0.06% 462
2019
Q1
$17K Buy
+700
New +$16.7K ﹤0.01% 1361

Other funds holding BHC

Walleye Capital's BHC Position: Q1 2026 in Review

Walleye Capital increased its Bausch Health (BHC) stake by 8,380% in Q1 2026, buying an estimated $6.96M and bringing the position to 1,177,370 shares worth $6.36M. The position accounts for 0.03% of the portfolio, ranked #647.

Walleye Capital first reported a position in BHC in Q1 2019 and has held it in 11 quarters since. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Walleye Capital held 1,177,370 shares of Bausch Health worth $6.36M as of Q1 2026.
  • Walleye Capital bought 1,163,486 Bausch Health shares in Q1 2026, an estimated $6.96M.
  • Bausch Health made up 0.03% of Walleye Capital's portfolio in Q1 2026, its #647 holding.
  • Walleye Capital first reported a position in Bausch Health in Q1 2019 and has held it in 11 quarters since.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.